CAV1 and breast cancer: Concomitantly CAV1 was downregulated in CAFs alongside other mesenchymal markers such as CD44 and VIM. Loss of CAF-specific Caveolin-1 expression has been reported to be linked to worse prognosis in multiple cancers including breast cancer [10].